Ageing is associated with significant immunological changes that can influence both the progression of the disease and the ...

Biostate AI and the Accelerated Cure Project will to develop AI models to predict multiple sclerosis progression and ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 ...

Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit organization dedicated to ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

A man with multiple sclerosis (MS) is about to undertake a feat of physical and mental endurance. Dominic Shadbolt, 53, from ...